Invertebrate models of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 33, Issue 1, 2013, Pages 3-16

  Mhatre, Siddhita D ^a   Paddock, Brie E ^b   Saunders, Aleister J ^a,c   Marenda, Daniel R ^a,c  

^a DREXEL UNIVERSITY   (United States)

^b ARCADIA UNIVERSITY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; C. elegans; Drosophila; model organisms; review

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; NICASTRIN; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; DISEASE CLASSIFICATION; DISEASE MODEL; DROSOPHILA MELANOGASTER; EARLY ONSET ALZHEIMER DISEASE; GENE MUTATION; GENE OVEREXPRESSION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; RISK ASSESSMENT; TAUOPATHY; TRANSGENE;

EID: 84872449762     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121204     Document Type: Review

References (142)

1. Nusslein-Volhard C, Wieschaus E (1980) Mutations affecting segment number and polarity in Drosophila. Nature 287, 795-801. (Pubitemid 11214475)
2. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71-94.
3. Ellis HM, Horvitz HR (1986) Genetic control of programmed cell death in the nematode C. elegans. Cell 44, 817-829. (Pubitemid 16045328)
4. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. (Pubitemid 28099681)
5. Lin YJ, Seroude L, Venzer S (1998) Extended life-span and stress resistance in the Drosophila mutant methuselah. Science 282, 943-946. (Pubitemid 28507527)
6. Zou S, Meadows S, Sharp L, Jan LY, Jan YN (2000) Genome-wide study of aging and oxidative stress response in Drosophila melanogaster. Proc Natl Acad Sci U S A 97, 13726-13731.
7. Zhan M, Yamaza H, Sun Y, Sinclair J, Li H, Zou S (2007) Temporal and spatial transcriptional profiles of aging in Drosophila melanogaster. Genome Res 17, 1236-1243. (Pubitemid 47204868)
8. Smith ED, Tsuchiya M, Fox LA, Dang N, Hu D, Kerr EO, Johnston ED, Tchao BN, Pak DN, Welton KL, Promislow DE, Thomas JH, Kaeberlein M, Kennedy BK (2008) Quantitative evidence for conserved longevity pathways between divergent eukaryotic species. Genome Res 18, 564-570. (Pubitemid 351482781)
9. Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: Back to the future. Neuron 68, 270-281.
10. Wu J, Basha MR, Zawia NH (2008) The environment, epigenetics and amyloidogenesis. J Mol Neurosci 34, 1-7. (Pubitemid 351378089)
11. Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship. J Neuropathol Exp Neurol 68, 1-14.
12. LaFerla FM, Oddo S (2005) Alzheimer's disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 11, 170-176.
13. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, WisniewskiHM(1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084-6089. (Pubitemid 17207447)
14. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83, 4913-4917.
15. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
16. DeStrooper B, AnnaertW(2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113(Pt 11), 1857-1870. (Pubitemid 30386490)
17. Yaari R, Corey-Bloom J (2007) Alzheimer's disease. Semin Neurol 27, 32-41. (Pubitemid 46239037)
18. Avramopoulos D (2009) Genetics of Alzheimer's disease: Recent advances. Genome Med 1, 34.
19. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99. (Pubitemid 21917324)
20. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, BruniAC,MontesiMP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Perkicak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
21. Tanzi RE, BertramL(2005)Twenty years of the Alzheimer's disease amyloid hypothesis:Agenetic perspective. Cell 120, 545-555. (Pubitemid 40269768)
22. Scheuner D, Eckman C, JensenM,Song X, CitronM,Suzuki N, Bird TD, Hardy J, Hutton M, KukullW, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2, 864-870. (Pubitemid 26296755)
23. Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303.
24. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39, 17-23. (Pubitemid 46026496)
25. Daigle I, Li C (1993) apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor. Proc Natl Acad Sci U S A 90, 12045-12049.
26. Rosen DR, Martin-Morris L, Luo LQ, White K (1989) A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. Proc Natl Acad Sci U S A 86, 2478-2482. (Pubitemid 19102532)
27. Luo LQ, Martin-Morris LE, White K (1990) Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor. J Neurosci 10, 3849-3861.
28. Hornsten A, Lieberthal J, Fadia S, Malins R, Ha L, Xu X, Daigle I, Markowitz M, O'Connor G, Plasterk R, Li C (2007) APL-1, a Caenorhabditis elegans protein related to the human beta-amyloid precursor protein, is essential for viability. Proc Natl Acad Sci U S A 104, 1971-1976. (Pubitemid 46239888)
29. Martin-Morris LE, White K (1990) The Drosophila transcript encoded by the beta-amyloid protein precursor-like gene is restricted to the nervous system. Development 110, 185-195.
30. Luo L, Tully T, White K (1992) Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron 9, 595-605.
31. Wiese M, Antebi A, ZhengH(2010) Intracellular trafficking and synaptic function of APL-1 in Caenorhabditis elegans. PLoS One 5, pii: e12790.
32. Wiese M, Antebi A, Zheng H (2012) Regulation of neuronal APL-1 expression by cholesterol starvation. PLoS One 7, e32038.
33. Goguel V, Belair AL, Ayaz D, Lampin-Saint-Amaux A, Scaplehorn N, Hassan BA, Preat T (2011) Drosophila amyloid precursor protein-like is required for long-term memory. J Neurosci 31, 1032-1037.
34. Leyssen M, Ayaz D, Hebert SS, Reeve S, De Strooper B, Hassan BA (2005) Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. EMBO J 24, 2944-2955. (Pubitemid 43079897)
35. Zhang C, Khandelwal PJ, Chakraborty R, Cuellar TL, Sarangi S, Patel SA, Cosentino CP, O'Connor M, Lee JC, Tanzi RE, Saunders AJ (2007) An AICD-based functional screen to identify APP metabolism regulators. Mol Neurodegener 2, 15.
36. Rooke J, Pan D, Xu T, Rubin GM (1996) KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Nature 273, 1227-1231. (Pubitemid 26293213)
37. Allinson TM, Parkin ET, Turner AJ, Hooper NM (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J Neurosci Res 74, 342-352. (Pubitemid 37362810)
38. Tax FE, Thomas JH, Ferguson EL, Horvitz HR (1997) Identification and characterization of genes that interact with lin-12 in Caenorhabditis elegans. Genetics 147, 1675-1695.
39. Wen C, Metzstein MM, Greenwald I (1997) SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signalling. Development 124, 4759-4767. (Pubitemid 28014379)
40. Jarriault S, Greenwald I (2005) Evidence for functional redundancy between C. elegans ADAM proteins SUP-17/Kuzbanian and ADM-4/TACE. Dev Biol 287, 1-10. (Pubitemid 41587473)
41. EwaldCY, LiC(2010) Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system. Brain Struct Funct 214, 263-283.
42. Carmine-Simmen K, Proctor T, Tschape J, Poeck B, Triphan T, Strauss R, Kretzschmar D (2009) Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Neurobiol Dis 33, 274-281.
43. Wentzell JS, Bolkan BJ, Carmine-Simmen K, Swanson TL, MusasheDT, KretzschmarD(2012) Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration. Neurobiol Dis 46, 78-87.
44. Kimberly WT, Ostaszewski BL, Ye W, Wolfe MS, Selkoe DJ (2003) Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci U S A 100, 6382-6387. (Pubitemid 36666590)
45. Hong CS, Koo EH (1997) Isolation and characterization of Drosophila presenilin homolog. Neuroreport 8, 665-668. (Pubitemid 27128213)
46. Chung HM, Struhl G (2001) Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. Nat Cell Biol 3, 1129-1132. (Pubitemid 33130465)
47. Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, Nicoll M, Maxwell M, Hai B, Ellis MC, Parks AL, XuW, Li J, GurneyM, Myers RL, Himes CS, Hiebsch R, Ruble C, Nye JS, Curtis D (2002) aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 3, 85-97. (Pubitemid 34778398)
48. Levitan D, Greenwald I (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354.
49. Levitan D, Greenwald I (1998) Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans. Development 125, 3599-3606. (Pubitemid 28469960)
50. Li X, Greenwald I (1997) HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc Natl Acad Sci U S A 94, 12204-12209. (Pubitemid 27467867)
51. Wen C, Levitan D, Li X, Greenwald I (2000) spr-2, a suppressor of the egg-laying defect caused by loss of sel-12 presenilin in Caenorhabditis elegans, is a member of the SET protein subfamily. Proc Natl Acad Sci U S A 97, 14524-14529. (Pubitemid 32016609)
52. Goutte C, Hepler W, Mickey KM, Priess JR (2000) aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling. Development 127, 2481-2492. (Pubitemid 30386585)
53. Chakraborty R,VepuriV, Mhatre SD, Paddock BE, Miller S, Michelson SJ, Delvadia R, Desai A, Vinokur M, Melicharek DJ, Utreja S, Khandelwal P, Ansaloni S, Goldstein LE, Moir RD, Lee JC, Tabb LP, Saunders AJ, Marenda DR (2011) Characterization of a Drosophila Alzheimer's disease model: Pharmacological rescue of cognitive defects. PLoS ONE 6, e20799.
54. Greeve I, Kretzschmar D, Tschape JA, Beyn A, Brellinger C, Schweizer M, Nitsch RM, Reifegerste R (2004) Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J Neurosci 24, 3899-3906. (Pubitemid 38544216)
55. Fossgreen A, Bruckner B, Czech C, Masters CL, Beyreuther K, Paro R (1998) Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. Proc Natl Acad Sci U S A 95, 13703-13708. (Pubitemid 28523036)
56. Wittenburg N, Eimer S, Lakowski B, Rohrig S, Rudolph C, Baumeister R (2000) Presenilin is required for proper morphology and function of neurons in C. elegans. Nature 406, 306-309. (Pubitemid 30604408)
57. Goedert M, Baur CP, Ahringer J, Jakes R, Hasegawa M, Spillantini MG, Smith MJ, Hill F (1996) PTL-1, a microtubule-associated protein with tau-like repeats from the nematode Caenorhabditis elegans. J Cell Sci 109(Pt 11), 2661-2672. (Pubitemid 26388351)
58. McDermott JB, Aamodt S, Aamodt E (1996) ptl-1, a Caenorhabditis elegans gene whose products are homologous to the tau microtubule-associated proteins. Biochemistry 35, 9415-9423. (Pubitemid 26320047)
59. Heidary G, Fortini ME (2001) Identification and characterization of the Drosophila tau homolog. Mech Dev 108, 171-178. (Pubitemid 32923065)
60. Doerflinger H, Benton R, Shulman JM, St JohnstonD(2003) The role of PAR-1 in regulating the polarised microtubule cytoskeleton in the Drosophila follicular epithelium. Development 130, 3965-3975. (Pubitemid 37063416)
61. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519. (Pubitemid 34628749)
62. Chatterjee S, Sang TK, Lawless GM, Jackson GR (2009) Dissociation of tau toxicity and phosphorylation: Role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum Mol Genet 18, 164-177.
63. Feuillette S, Miguel L, Frebourg T, Campion D, Lecourtois M (2010) Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. J Neurochem 113, 895-903.
64. Dickman DK, Lu Z, Meinertzhagen IA, Schwarz TL (2006) Altered synaptic development and active zone spacing in endocytosis mutants. Curr Biol 16, 591-598.
65. Bao H, Daniels RW, MacLeod GT, Charlton MP, Atwood HL, Zhang B (2005) AP180 maintains the distribution of synaptic and vesicle proteins in the nerve terminal and indirectly regulates the efficacy of Ca2+-triggered exocytosis. J Neurophysiol 94, 1888-1903. (Pubitemid 41192861)
66. Nonet ML, Holgado AM, Brewer F, Serpe CJ, Norbeck BA, Holleran J, Wei L, Hartwieg E, Jorgensen EM, Alfonso A (1999) UNC-11, a Caenorhabditis elegans AP180 homologue, regulates the size and protein composition of synaptic vesicles. Mol Biol Cell 10, 2343-2360. (Pubitemid 29343139)
67. Mathew D, Popescu A, Budnik V (2003) Drosophila amphiphysin functions during synaptic Fasciclin II membrane cycling. J Neurosci 23, 10710-10716. (Pubitemid 37485285)
68. Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, BaruV, Shulman JM, Parrado A, Bevis BJ,Valastyan JS, Han H, Lindhagen-Persson M, Reiman EM,EvansDA, Bennett DA, Olofsson A, DeJager PL, Tanzi RE, Caldwell KA, Caldwell GA, Lindquist S (2011) Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 334, 1241-1245.
69. Lee YN, Shim YJ, Kang BH, Park JJ, Min BH (2012) Overexpression of human clusterin increases stress resistance and extends lifespan in Drosophila melanogaster. Biochem Biophys Res Commun 420, 851-856.
70. Glenner GC, Wong CW (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890. (Pubitemid 14104991)
71. Tanzi RE, BertramL(2005)Twenty years of the Alzheimer's disease amyloid hypothesis:Agenetic perspective. Cell 120, 545-555. (Pubitemid 40269768)
72. Link CD (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A 92, 9368-9372.
73. Fay DS, Fluet A, Johnson CJ, Link CD (1998) In vivo aggregation of beta-amyloid peptide variants. J Neurochem 71, 1616-1625. (Pubitemid 28443034)
74. Link CD, Taft A, Kapulkin V, Duke K, Kim S, Fei Q,Wood DE, SahaganBG(2003) Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol Aging 24, 397-413. (Pubitemid 36205048)
75. Dosanjh LE, Brown MK, Rao G, Link CD, Luo Y (2010) Behavioral phenotyping of a transgenic Caenorhabditis elegans expressing neuronal amyloid-beta. J Alzheimers Dis 19, 681-690.
76. McColl G, Roberts BR, Gunn AP, Perez KA, Tew DJ, Masters CL, Barnham KJ, Cherny RA, Bush AI (2009) The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42. J Biol Chem 284, 22697-22702.
77. Finelli A, Kelkar A, Song HJ, Yang H, Konsolaki M (2004) Amodel for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster. Mol Cell Neurosci 26, 365-375. (Pubitemid 38968431)
78. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292, 1550-1552. (Pubitemid 32493424)
79. Iijima-Ando K, Hearn SA, Granger L, Shenton C, Gatt A, Chiang HC, Hakker I, Zhong Y, Iijima K (2008) Overexpression of neprilysin reduces alzheimer amyloidbeta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMPresponsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila. J Biol Chem 283, 19066-19076.
80. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y (2004) Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: A potential model for Alzheimer's disease. Proc Natl Acad Sci U S A 101, 6623-6628. (Pubitemid 38586024)
81. Iijima K, Chiang HC, Hearn SA, Hakker I, Gatt A, Shenton C, Granger L, Leung A, Iijima-Ando K, Zhong Y (2008) Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS One 3, e1703.
82. Iijima-Ando K, Hearn SA, Shenton C, Gatt A, Zhao L, Iijima K (2009) Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One 4, e8310.
83. McGuire SE, Mao Z, Davis RL (2004) Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila. Sci STKE 2004, p. l6.
84. Sofola O, Kerr F, Rogers I, Killick R, Augustin H, Gandy C, Allen MJ, Hardy. J, Lovestone S, Partridge L (2010) Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet 6, pii: e1001087.
85. Zhou ZD, Chan CH, Ma QH, Xu XH, Xiao ZC, Tan EK (2011) The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease. Cell Adh Migr 5, 280-292.
86. Torroja L, Chu H, Kotovsky I, White K (1999) Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr Biol 9, 489-492. (Pubitemid 29228622)
87. Torroja L, Packard M, Gorczyca M, White K, Budnik V (1999) The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci 19, 7793-7803. (Pubitemid 30225778)
88. Gunawardena S, Goldstein LS (2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389-401. (Pubitemid 33082041)
89. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736. (Pubitemid 17054046)
90. Sheng B, Song B, Zheng Z, Zhou F, Lu G, Zhao N, Zhang X, Gong Y (2009) Abnormal cleavage of APP impairs its functions in cell adhesion and migration. Neurosci Lett 450, 327-331.
91. Gross GG, Feldman RM, Ganguly A, Wang J, Yu H, Guo M (2008) Role of X11 and ubiquilin as in vivo regulators of the amyloid precursor protein in Drosophila. PLoS ONE 3, e2495.
92. Guo M, Hong EJ, Fernandes J, Zipursky SL, Hay BA (2003) A reporter for amyloid precursor protein gamma-secretase activity in Drosophila. Hum Mol Genet 12, 2669-2678. (Pubitemid 37304689)
93. Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415. (Pubitemid 23214028)
94. Cao X, Sudhof TC (2001) A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120. (Pubitemid 32625507)
95. Boulianne GL, Livne-Bar I, Humphreys JM, Liang Y, Lin C, Rogaev E, St George-Hyslop P (1997) Cloning and characterization of the Drosophila presenilin homologue. Neuroreport 8, 1025-1029. (Pubitemid 27152167)
96. Sarantseva S, Timoshenko S, Bolshakova O, Karaseva E, Rodin D, Schwarzman AL,VitekMP(2009) Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease. PLoS One 4, e8191.
97. Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ (1991) A68: A major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251, 675-678. (Pubitemid 21916893)
98. Weaver CL, Espinoza M, Kress Y, Davies P (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging 21, 719-727.
99. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, SchellenbergGD(1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43, 815-825. (Pubitemid 28280226)
100. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F,Tannenberg T, Dodd PR, Hayward N,Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P (1998) Association of missense and 5-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
101. Mandelkow EM, Biernat J, Drewes G, Steiner B, Lichtenberg-Kraag B, Wille H, Gustke N, Mandelkow E (1993) Microtubule-associated protein tau, paired helical filaments, and phosphorylation. Ann N Y Acad Sci 695, 209-216. (Pubitemid 23348263)
102. Mandelkow EM, Mandelkow E (1993) Tau as a marker for Alzheimer's disease. Trends Biochem Sci 18, 480-483. (Pubitemid 23362306)
103. Umahara T, Tsuchiya K, Ikeda K, Kanaya K, Iwamoto T, Takasaki M, Mukai K, Shibata N, Kato S (2002) Demonstration and distribution of tau-positive glial coiled body-like structures in white matter and white matter threads in early onset Alzheimer's disease. Neuropathology 22, 9-12. (Pubitemid 34538681)
104. Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, Kayed R (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J 26, 1946-1959.
105. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 99, 6364-6369. (Pubitemid 34493317)
106. Park SY, Ferreira A (2005) The generation of a 17 kDa neurotoxic fragment: An alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25, 5365-5375. (Pubitemid 40770916)
107. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754. (Pubitemid 46717684)
108. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421. (Pubitemid 36937044)
109. Oddo S, Caccamo A, Tseng B, Cheng D,VasilevkoV, Cribbs DH, LaFerla FM (2008) Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: A mechanistic link between Abeta and tau pathology. J Neurosci 28, 12163-12175.
110. Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F (2008) Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 172, 786-798. (Pubitemid 351354550)
111. Folwell J, Cowan CM, Ubhi KK, Shiabh H, Newman TA, Shepherd D, Mudher A (2010) Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Exp Neurol 223, 401-409.
112. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72, 1858-1862.
113. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33, 95-130.
114. Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys 357, 299-309. (Pubitemid 28419212)
115. Lin YT, Cheng JT, Liang LC, Ko CY, Lo YK, Lu PJ (2007) The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta. J Neurochem 103, 802-813.
116. Cho JH, Johnson GV (2004) Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules. J Neurochem 88, 349-358. (Pubitemid 38084551)
117. Kosmidis S, Grammenoudi S, Papanikolopoulou K, Skoulakis EM (2010) Differential effects of Tau on the integrity and function of neurons essential for learning in Drosophila. J Neurosci 30, 464-477.
118. Grammenoudi S, Anezaki M, Kosmidis S, Skoulakis EM (2008) Modelling cell and isoform type specificity of tauopathies in Drosophila. SEB Exp Biol Ser 60, 39-56.
119. Williams DW, Tyrer M, Shepherd D (2000) Tau and tau reporters disrupt central projections of sensory neurons in Drosophila. J Comp Neurol 428, 630-640.
120. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711-714. (Pubitemid 32728676)
121. Dias-Santagata D, Fulga TA, Duttaroy A, FeanyMB (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 117, 236-245. (Pubitemid 46055207)
122. Chee FC, Mudher A, Cuttle MF, Newman TA, MacKay D, Lovestone S, Shepherd D (2005) Over-Expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol Dis 20, 918-928. (Pubitemid 41619367)
123. Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, Mandelkow EM, Feany MB (2007) S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J Neurosci Res 85, 1271-1278. (Pubitemid 46724370)
124. Yeh PA, Chien JY, Chou CC, Huang YF, Tang CY, Wang HY, SuMT (2010) Drosophila notal bristle as a novel assessment tool for pathogenic study of Tau toxicity and screening of therapeutic compounds. Biochem Biophys Res Commun 391, 510-516.
125. McGuire SE, Mao Z, Davis RL (2004) Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila. Sci STKE 2004, p. l6.
126. Colodner KJ, Feany MB (2010) Glial fibrillary tangles and JAK/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy. J Neurosci 30, 16102-16113.
127. Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD (2003) Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A 100, 9980-9985. (Pubitemid 37087054)
128. Miyasaka T, Ding Z, Gengyo-Ando K, Oue M, Yamaguchi H, Mitani S, Ihara Y (2005) Progressive neurodegeneration in C. elegans model of tauopathy. Neurobiol Dis 20, 372-383. (Pubitemid 41476263)
129. Kraemer BC, Burgess JK, Chen JH, Thomas JH, Schellenberg GD (2006) Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Hum Mol Genet 15, 1483-1496.
130. Kraemer BC, Schellenberg GD (2007) SUT-1 enables tauinduced neurotoxicity in C.elegans. Hum Mol Genet 16, 1959-1971. (Pubitemid 47354879)
131. Guthrie CR, Schellenberg GD, Kraemer BC (2009) SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. Hum Mol Genet 18, 1825-1838.
132. Guthrie CR, Greenup L, Leverenz JB, Kraemer BC (2011) MSUT2 is a determinant of susceptibility to tau neurotoxicity. Hum Mol Genet 20, 1989-1999.
133. Park H, Kam TI, Kim Y, Choi H, Gwon Y, Kim C, Koh JY, Jung YK (2012) Neuropathogenic role of adenylate kinase-1 in Abeta-mediated tau phosphorylation via AMPK and GSK3beta. Hum Mol Genet 21, 2725-2737.
134. Gotz J, Chen F, van Dorpe J, NitschRM(2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293, 1491-1495. (Pubitemid 32807681)
135. Fulga TA, Elson-Schwab I, KhuranaV, Steinhilb ML, Spires TL, Hyman BT, Feany MB (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9, 139-148. (Pubitemid 46420856)
136. Mershin A, Pavlopoulos E, Fitch O, Braden BC, Nanopoulos DV, Skoulakis EM (2004) Learning and memory deficits uponTAUaccumulation in Drosophila mushroom body neurons. Learn Mem 11, 277-287. (Pubitemid 38697893)
137. Chen X, Li Y, Huang J, Cao D, Yang G, Liu W, Lu H, Guo A (2007) Study of tauopathies by comparing Drosophila and human tau in Drosophila. Cell Tissue Res 329, 169-178. (Pubitemid 46686106)
138. Ubhi KK, Shaibah H, Newman TA, Shepherd D, Mudher A (2007) A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies. Invert Neurosci 7, 165-171. (Pubitemid 47339788)
139. Link CD (2006) C. elegans models of age-associated neurodegenerative diseases: Lessons from transgenic worm models of Alzheimer's disease. Exp Gerontol 41, 1007-1013. (Pubitemid 44821699)
140. Brandt R, Gergou A, Wacker I, Fath T, Hutter H (2009) A Caenorhabditis elegans model of tau hyperphosphorylation: Induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau. Neurobiol Aging 30, 22-33.
141. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB (2001) Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles. Science 293, 711-714. (Pubitemid 32728676)
142. Shulman JM, Shulman LM, Weiner WJ, Feany MB (2003) From fruit fly to bedside: Translating lessons from Drosophila models of neurodegenerative disease. Curr Opin Neurol 16, 443-449. (Pubitemid 36951819)